Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Anti-CD152 Antibody - Pipeline Insight, 2025
... for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages Clinical ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Anti-CD19 Antibody: Understanding Anti-CD19 Antibody: ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2025
... for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages Clinical ... Read More
-
Antibody Library Technologies
... at a CAGR of 4.1% over the analysis period 2024-2030. Phage Display Technology, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$147.1 Million by the end ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Antibody Production
... CAGR of 10.4% over the analysis period 2024-2030. Monoclonal Antibody, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$27.4 Billion by the end of the analysis ... Read More
-
Monoclonal Antibodies
... CAGR of 6.7% over the analysis period 2024-2030. Human, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$105.2 Billion by the end of the analysis period. ... Read More
-
Intravenous Immunoglobulin (IVIg)
... at a CAGR of 8.5% over the analysis period 2024-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Immunochemicals
... 5.1% over the analysis period 2024-2030. Catalog Antibodies, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth ... Read More
-
Cell-free Protein Expression Market Report by Product (Expression Systems, Reagents), Method (Transcription and Translation Systems, Translation Systems), Application (Enzyme Engineering, High Throughput Production, Protein Labeling, Protein-Protein Interaction, Protein Purification), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others), and Region 2025-2033
... 2025-2033. The market is experiencing significant growth mainly driven by advancements in personalized medicine, vaccine development, and synthetic biology. The rising demand for cost-effective, flexible solutions in pharmaceuticals and biotechnology further propels market growth, positioning ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2025
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2025
... for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages Clinical ... Read More
-
Systemic Radiotherapy
... CAGR of 4.0% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$919.6 Million by the end of the analysis period. ... Read More
-
Subcutaneous Immunoglobulin
... CAGR of 13.7% over the analysis period 2024-2030. Primary Immunodeficiency Diseases, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$12.0 Billion by the end of the ... Read More
-
Antinuclear Antibody Testing
... at a CAGR of 11.1% over the analysis period 2024-2030. Reagents & Assay Kits, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$2.1 Billion by the ... Read More
-
Combination Antibody Therapy
... at a CAGR of 14.0% over the analysis period 2024-2030. Chemotherapy / Antibody Therapy, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$169.7 Billion by the ... Read More
-
Immunoprecipitation
... 5.8% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$457.9 Million by the end of the analysis period. Growth in ... Read More
-
Single-Use Bioreactors
... CAGR of 15.1% over the analysis period 2024-2030. Single-Use Bioreactor Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$6.1 Billion by the end of the ... Read More
-
Protein Therapeutics
... CAGR of 5.8% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$284.7 Billion by the end of the analysis ... Read More
-
Serological Transplant Diagnostics
... at a CAGR of 8.6% over the analysis period 2024-2030. Reagents & Accessories, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.6 Billion by the end ... Read More
-
HER2 Antibodies
... CAGR of 7.3% over the analysis period 2024-2030. Trastuzumab, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$20.5 Billion by the end of the analysis period. ... Read More
-
2025 Global Functional Proteins Market Industry (2031 Outlook)
... a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology analysis, ... Read More
-
Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031)
... segmentation By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channel) for the historical period of 2021-2024, ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2025
... for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages Clinical ... Read More
Research Assistance
